Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Peptic Ulcer

  Free Subscription


Articles published in J Gastroenterol Hepatol

Retrieve available abstracts of 69 articles:
HTML format
Text format



Single Articles


    January 2020
  1. IN SEO S, You SC, Park CH, Kim TJ, et al
    Comparative Risk of Clostridium difficile Infection between Proton Pump Inhibitors and Histamine-2 Receptor Antagonists: A 15-year Hospital Cohort Study Using a Common Data Model.
    J Gastroenterol Hepatol. 2020 Jan 23. doi: 10.1111/jgh.14983.
    PubMed     Text format     Abstract available


  2. YIN G, Bie S, Gu H, Shu X, et al
    Application of gene chip technology in the diagnostic and drug resistance detection of Helicobacter pylori in children.
    J Gastroenterol Hepatol. 2020 Jan 12. doi: 10.1111/jgh.14980.
    PubMed     Text format     Abstract available


  3. SHUNG DL, Sung JJY
    A new scoring system for upper gastrointestinal bleeding: Too simple or still complicated?
    J Gastroenterol Hepatol. 2020;35:5.
    PubMed     Text format    


    December 2019
  4. HONG AS, Yu WY, Hong JM, Cross CL, et al
    PROTON PUMP INHIBITOR IN UPPER GASTROINTESTINAL FECAL MICROBIOTA TRANSPLANT: A SYSTEMATIC REVIEW AND ANALYSIS.
    J Gastroenterol Hepatol. 2019 Dec 12. doi: 10.1111/jgh.14958.
    PubMed     Text format     Abstract available


  5. DU Y, Zhu H, Liu J, Li J, et al
    Consensus on eradication of Helicobacter pylori and prevention & control of gastric cancer in China (2019, Shanghai).
    J Gastroenterol Hepatol. 2019 Dec 1. doi: 10.1111/jgh.14947.
    PubMed     Text format     Abstract available


    November 2019
  6. MYINT NPST, Zaw TT, Sain K, Waiyan S, et al
    Sequential Helicobacter pylori eradication therapy in Myanmar; a randomized clinical trial of efficacy and tolerability.
    J Gastroenterol Hepatol. 2019 Nov 23. doi: 10.1111/jgh.14942.
    PubMed     Text format     Abstract available


  7. NOTSU T, Adachi K, Mishiro T, Ishimura N, et al
    Fundic gland polyp prevalence according to Helicobacter pylori infection status.
    J Gastroenterol Hepatol. 2019 Nov 16. doi: 10.1111/jgh.14934.
    PubMed     Text format     Abstract available


  8. WU CK, Yang SC, Liang CM, Li YC, et al
    The role of antibiotics in upper gastrointestinal bleeding among cirrhotic patients without major complications after endoscopic hemostasis.
    J Gastroenterol Hepatol. 2019 Nov 1. doi: 10.1111/jgh.14873.
    PubMed     Text format     Abstract available


  9. BAIR MJ, Chuang SL, Lei WY, Chen CL, et al
    Planning Mass Eradication of Helicobacter pylori Infection for Indigenous Taiwanese Peoples to Reduce Gastric Cancer.
    J Gastroenterol Hepatol. 2019 Nov 1. doi: 10.1111/jgh.14898.
    PubMed     Text format     Abstract available


    August 2019
  10. ZHANG F, Wang F, Chen C, Wang T, et al
    CYP3A4 predicts progression of chronic atrophic gastritis with Helicobacter pylori and poor prognosis of gastric cancer.
    J Gastroenterol Hepatol. 2019 Aug 23. doi: 10.1111/jgh.14844.
    PubMed     Text format     Abstract available


  11. CHEN MJ, Fang YJ, Wu MS, Chen CC, et al
    Application of Helicobacter pylori stool antigen test to survey the updated prevalence of H. pylori infection in Taiwan.
    J Gastroenterol Hepatol. 2019 Aug 13. doi: 10.1111/jgh.14828.
    PubMed     Text format     Abstract available


  12. TANAKA S, Toyonaga T, Kawara F, Watanabe D, et al
    The novel per-oral endoscopic myotomy method preserving oblique muscle using two penetrating vessels as anatomic landmarks reduces postoperative gastroesophageal reflux.
    J Gastroenterol Hepatol. 2019 Aug 1. doi: 10.1111/jgh.14814.
    PubMed     Text format     Abstract available


    July 2019
  13. SARKESHIKIAN SS, Ghadir MR, Alemi F, Jalali SM, et al
    Atorvastatin in combination with conventional antimicrobial treatment of Helicobacter pylori eradication: A randomized controlled clinical trial.
    J Gastroenterol Hepatol. 2019 Jul 29. doi: 10.1111/jgh.14810.
    PubMed     Text format     Abstract available


  14. HUSSAIN S, Singh A, Zameer S, Jamali MC, et al
    No association between proton pump inhibitors use and risk of dementia: Evidence from a meta-analysis.
    J Gastroenterol Hepatol. 2019 Jul 23. doi: 10.1111/jgh.14789.
    PubMed     Text format     Abstract available


  15. SIVANES S, Chang J
    Gastrointestinal: A rare cause of upper gastrointestinal bleeding: Epiphrenic esophageal diverticula.
    J Gastroenterol Hepatol. 2019 Jul 4. doi: 10.1111/jgh.14755.
    PubMed     Text format    


  16. DEGUCHI H, Yamazaki H, Yamamoto Y, Fukuhara S, et al
    Association between parental history of Helicobacter pylori treatment failure and treatment failure in the offspring.
    J Gastroenterol Hepatol. 2019 Jul 1. doi: 10.1111/jgh.14774.
    PubMed     Text format     Abstract available


    June 2019
  17. JIANG K, Jiang X, Wen Y, Liao L, et al
    Relationship between long-term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis.
    J Gastroenterol Hepatol. 2019 Jun 17. doi: 10.1111/jgh.14759.
    PubMed     Text format     Abstract available


    May 2019
  18. PARK SK, Nam JH, Lee H, Chung H, et al
    Beyond uncertainty: negative findings for the association between the use of proton pump inhibitors and risk of dementia.
    J Gastroenterol Hepatol. 2019 May 30. doi: 10.1111/jgh.14745.
    PubMed     Text format     Abstract available


  19. HSU PI, Pan CY, Kao JY, Tsay FW, et al
    Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.
    J Gastroenterol Hepatol. 2019 May 22. doi: 10.1111/jgh.14736.
    PubMed     Text format     Abstract available


  20. ADACHI K, Notsu T, Mishiro T, Kinoshita Y, et al
    Long-term effect of Helicobacter pylori eradication on prevalence of reflux esophagitis.
    J Gastroenterol Hepatol. 2019 May 21. doi: 10.1111/jgh.14730.
    PubMed     Text format     Abstract available


  21. YORITA N, Ito M, Boda T, Kotachi T, et al
    Potential of Helicobacter pylori-uninfected signet ring cell carcinoma to invade the submucosal layer.
    J Gastroenterol Hepatol. 2019 May 7. doi: 10.1111/jgh.14706.
    PubMed     Text format     Abstract available


    April 2019
  22. WONG SH, Sung JJ
    When repeated Helicobacter pylori therapies fail, what should we do?
    J Gastroenterol Hepatol. 2019;34:627-628.
    PubMed     Text format    


    March 2019
  23. PITTAYANON R, Piyachaturawat P, Rerknimitr R, Prueksapanich P, et al
    Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double-blind placebo-controlled trial.
    J Gastroenterol Hepatol. 2019 Mar 28. doi: 10.1111/jgh.14671.
    PubMed     Text format     Abstract available


  24. MIYAZAKI H, Igarashi A, Takeuchi T, Teng L, et al
    Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: a systematic review.
    J Gastroenterol Hepatol. 2019 Mar 18. doi: 10.1111/jgh.14664.
    PubMed     Text format     Abstract available


  25. FOUAD TR, Abdelsameea E, Abdel-Razek W, Attia A, et al
    Upper gastrointestinal bleeding in Egyptian patients with cirrhosis: Post-therapeutic outcome and prognostic indicators.
    J Gastroenterol Hepatol. 2019 Mar 14. doi: 10.1111/jgh.14659.
    PubMed     Text format     Abstract available


  26. WONG MW, Bair MJ, Chang WC, Hsu CS, et al
    Clinical and psychological characteristics in GERD patients overlapping with laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2019 Mar 8. doi: 10.1111/jgh.14651.
    PubMed     Text format     Abstract available


    February 2019
  27. CHOI YK, Ahn JY, Won SH, Jung K, et al
    Eradication rate of Helicobacter pylori reinfection in Korea: A retrospective study.
    J Gastroenterol Hepatol. 2019 Feb 27. doi: 10.1111/jgh.14639.
    PubMed     Text format     Abstract available


  28. LIOU TC, Liao PH, Lin YC, Chu CH, et al
    Intraluminal therapy for Helicobacter pylori infection.
    J Gastroenterol Hepatol. 2019 Feb 8. doi: 10.1111/jgh.14627.
    PubMed     Text format     Abstract available


  29. LEE JW, Kim N, Nam RH, Lee SM, et al
    Risk factors of rescue bismuth quadruple therapy failure for Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2019 Feb 6. doi: 10.1111/jgh.14625.
    PubMed     Text format     Abstract available


  30. HASHIMOTO R, Matsuda T
    Gastrointestinal: Endoscopic findings of monomorphic epitheliotropic intestinal T-cell lymphoma.
    J Gastroenterol Hepatol. 2019;34:311.
    PubMed     Text format    


  31. MATSUMOTO Y, Ota K, Yamada H
    Gastrointestinal: Intestinal Behcet's disease-like ulcers associated with myelodysplastic syndrome with monosomy 7.
    J Gastroenterol Hepatol. 2019;34:310.
    PubMed     Text format    


    January 2019
  32. CHAN JSH, Chao ACW, Cheung VCH, Wong SSK, et al
    Gastrointestinal disease burden and mortality: A public hospital-based study from 2005 to 2014.
    J Gastroenterol Hepatol. 2019;34:124-131.
    PubMed     Text format     Abstract available


    December 2018
  33. WANG KY, Chen YW, Wang TN, Hsu WH, et al
    Predictor of Slower Gastric Emptying in Gastroesophageal Reflux Disease-Survey of An Asian-Pacific Cohort.
    J Gastroenterol Hepatol. 2018 Dec 14. doi: 10.1111/jgh.14572.
    PubMed     Text format     Abstract available



  34. Retraction: Usefulness of Helicobacter pylori eradication for precancerous lesions of the gastric remnant.
    J Gastroenterol Hepatol. 2018;33:2055.
    PubMed     Text format    


    November 2018
  35. ZHENG W, Jiang L, Jia X, Long G, et al
    Analysis of risk factors and development of scoring system to predict severity of upper gastrointestinal bleeding in children.
    J Gastroenterol Hepatol. 2018 Nov 21. doi: 10.1111/jgh.14548.
    PubMed     Text format     Abstract available


  36. SARRI GL, Grigg SE, Yeomans ND
    Helicobacter pylori increases the risk of low-dose aspirin ulcers: A meta-analysis.
    J Gastroenterol Hepatol. 2018 Nov 8. doi: 10.1111/jgh.14539.
    PubMed     Text format     Abstract available


    August 2018
  37. YEO YH, Hsu CC, Lee CC, Ho HJ, et al
    Systematic review with network meta-analysis: Effectiveness of therapies for second-line Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2018 Aug 31. doi: 10.1111/jgh.14462.
    PubMed     Text format     Abstract available


  38. SUE S, Shibata W, Sasaki T, Kaneko H, et al
    Randomized Trial of Vonoprazan- Versus PPI-Based Third-Line Triple Therapy With Sitafloxacin for Helicobacter pylori.
    J Gastroenterol Hepatol. 2018 Aug 27. doi: 10.1111/jgh.14456.
    PubMed     Text format     Abstract available


  39. WU SC, Chen WT, Muo CH, Hsu CY, et al
    A comparative study of subsequent liver cirrhosis risk in non- helicobacter pylori infected peptic ulcer patients with and without vagotomy: an Asian population cohort study.
    J Gastroenterol Hepatol. 2018 Aug 12. doi: 10.1111/jgh.14440.
    PubMed     Text format     Abstract available


  40. MOURAD FH, Leong RW
    Role of hemostatic powders in the management of lower gastrointestinal bleeding: A review.
    J Gastroenterol Hepatol. 2018;33:1445-1453.
    PubMed     Text format     Abstract available


    July 2018
  41. CHO JH, Jeon SR, Kim HG, Jin SY, et al
    Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients.
    J Gastroenterol Hepatol. 2018 Jul 16. doi: 10.1111/jgh.14383.
    PubMed     Text format     Abstract available


    June 2018
  42. ADACHI K, Notsu T, Mishiro T, Yoshikawa H, et al
    Influence of Helicobacter pylori infection on periodontitis.
    J Gastroenterol Hepatol. 2018 Jun 22. doi: 10.1111/jgh.14358.
    PubMed     Text format     Abstract available


    May 2018
  43. AUESOMWANG C, Maneerattanaporn M, Chey WD, Kiratisin P, et al
    Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
    J Gastroenterol Hepatol. 2018 May 27. doi: 10.1111/jgh.14292.
    PubMed     Text format     Abstract available


  44. MIN YW, Kim Y, Gwak GY, Gu S, et al
    Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study.
    J Gastroenterol Hepatol. 2018;33:1053-1058.
    PubMed     Text format     Abstract available


    March 2018
  45. LU B, Zhang L, Wang J, Wang B, et al
    Empirical treatment of outpatients with gastroesophageal reflux disease with proton pump inhibitors: a survey of Chinese patients (the ENLIGHT Study).
    J Gastroenterol Hepatol. 2018 Mar 25. doi: 10.1111/jgh.14143.
    PubMed     Text format     Abstract available


  46. CHOWDHRY M, Shah K, Kemper S, Zekan D, et al
    Proton pump inhibitors are not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    J Gastroenterol Hepatol. 2018 Mar 7. doi: 10.1111/jgh.14141.
    PubMed     Text format     Abstract available


  47. GOH KL
    Lessons Learnt from the Epidemiology of Helicobacter Pylori Infection in Malaysia Jghf Marshall and Warren Lecture 2017.
    J Gastroenterol Hepatol. 2018 Mar 2. doi: 10.1111/jgh.14131.
    PubMed     Text format     Abstract available


  48. OKANO A, Ohana M
    Gastrointestinal: Improvement of refractory oral ulcer of Behcet's disease after eradication of Helicobacter pylori.
    J Gastroenterol Hepatol. 2018;33:560.
    PubMed     Text format    


    February 2018
  49. PARK JC, Kim YJ, Kim EH, Lee J, et al
    Effectiveness of the polysaccharide hemostatic powder in non-variceal upper gastrointestinal bleeding: using propensity score matching.
    J Gastroenterol Hepatol. 2018 Feb 7. doi: 10.1111/jgh.14118.
    PubMed     Text format     Abstract available


    January 2018
  50. ROBERTS-THOMSON IC
    THE RISE AND FALL OF PEPTIC ULCERATION: A DISEASE OF CIVILIZATION?
    J Gastroenterol Hepatol. 2018 Jan 10. doi: 10.1111/jgh.14090.
    PubMed     Text format     Abstract available


    December 2017
  51. TAKAHASHI Y, Takeuchi T, Kojima Y, Nagami Y, et al
    Efficacy and safety of Helicobacter pylori eradication therapy immediately after endoscopic submucosal dissection.
    J Gastroenterol Hepatol. 2017 Dec 19. doi: 10.1111/jgh.14073.
    PubMed     Text format     Abstract available


  52. MA J, Hiratsuka T, Etoh T, Akada J, et al
    Anti-proliferation effect of blue light-emitting diodes against antibiotic-resistant Helicobacter pylori.
    J Gastroenterol Hepatol. 2017 Dec 7. doi: 10.1111/jgh.14066.
    PubMed     Text format     Abstract available


    November 2017
  53. XU MY, Ma JH, Yuan BS, Yin J, et al
    Association between helicobacter pylori infection and gallbladder diseases: a retrospective study.
    J Gastroenterol Hepatol. 2017 Nov 27. doi: 10.1111/jgh.14054.
    PubMed     Text format     Abstract available


  54. MISHIRO T, Oka K, Kuroki Y, Takahashi M, et al
    Proton pump inhibitor alters oral microbiome in gastrointestinal tract of healthy volunteers.
    J Gastroenterol Hepatol. 2017 Nov 4. doi: 10.1111/jgh.14040.
    PubMed     Text format     Abstract available


  55. KIM GU, Seo M, Song EM, Hwang SW, et al
    Association between the ulcer status and the risk of delayed bleeding after the endoscopic mucosal resection of colon.
    J Gastroenterol Hepatol. 2017;32:1846-1851.
    PubMed     Text format     Abstract available


    September 2017
  56. MANABE N, Haruma K, Kusunoki H, Kamada T, et al
    Differences in Salivary Secretory Function between Patients with Erosive Esophagitis and Those with Nonerosive Reflux Disease.
    J Gastroenterol Hepatol. 2017 Sep 27. doi: 10.1111/jgh.14002.
    PubMed     Text format     Abstract available


    July 2017
  57. MIN S, Kim N, Kwon YH, Hee R, et al
    RdxA, frxA and efflux pump in metronidazole-resistant Helicobacter pylori: their relation to clinical outcomes.
    J Gastroenterol Hepatol. 2017 Jul 27. doi: 10.1111/jgh.13906.
    PubMed     Text format     Abstract available


  58. AGARWAL J, Hasan A, Mehrotra M
    Hepatobiliary and Pancreatic: Hepatogastric fistula.
    J Gastroenterol Hepatol. 2017;32:1284.
    PubMed     Text format    


    May 2017
  59. YANG EH, Cheng HC, Wu CT, Chen WY, et al
    Peptic ulcer bleeding patients with Rockall Scores >/= 6 are at risk of long-term ulcer rebleeding: a 3.5-year prospective longitudinal study.
    J Gastroenterol Hepatol. 2017 May 11. doi: 10.1111/jgh.13822.
    PubMed     Text format     Abstract available


  60. KIM JH, Lim KS, Min YW, Lee H, et al
    Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis.
    J Gastroenterol Hepatol. 2017;32:1064-1070.
    PubMed     Text format     Abstract available


    January 2017
  61. BATCHELOR R, Gilmartin JF, Kemp W, Hopper I, et al
    Dementia, cognitive impairment and proton pump inhibitor therapy - a systematic review.
    J Gastroenterol Hepatol. 2017 Jan 27. doi: 10.1111/jgh.13750.
    PubMed     Text format     Abstract available


  62. EUSEBI LH, Rabitti S, Artesiani ML, Gelli D, et al
    PROTON PUMP INHIBITORS: RISKS OF LONG-TERM USE.
    J Gastroenterol Hepatol. 2017 Jan 16. doi: 10.1111/jgh.13737.
    PubMed     Text format     Abstract available


  63. LEE YC, Lin JT
    Screening and Treating Helicobacter pylori Infection for Gastric Cancer Prevention on the Population Level.
    J Gastroenterol Hepatol. 2017 Jan 14. doi: 10.1111/jgh.13726.
    PubMed     Text format     Abstract available


  64. GONG EJ, Choi KD, Jung HK, Youn YH, et al
    Quality of life, patient satisfaction, and disease burden in patients with gastroesophageal reflux disease with or without laryngopharyngeal reflux symptoms.
    J Gastroenterol Hepatol. 2017 Jan 3. doi: 10.1111/jgh.13716.
    PubMed     Text format     Abstract available


  65. KONO Y, Kawano S, Takaki A, Shimomura Y, et al
    Oxidative stress controlling agents are effective for small intestinal injuries induced by non-steroidal anti-inflammatory drugs.
    J Gastroenterol Hepatol. 2017;32:136-145.
    PubMed     Text format     Abstract available


    December 2016
  66. ZOU D, Goh KL
    An East Asian Perspective on the Interaction between Proton Pump Inhibitors and Clopidogrel.
    J Gastroenterol Hepatol. 2016 Dec 26. doi: 10.1111/jgh.13712.
    PubMed     Text format     Abstract available


    November 2016
  67. ON ZX, Grant J, Shi Z, Taylor AW, et al
    The association between gastroesophageal reflux disease (GERD) with sleep quality, depression and anxiety in a cohort study of Australian men.
    J Gastroenterol Hepatol. 2016 Nov 11. doi: 10.1111/jgh.13650.
    PubMed     Text format     Abstract available


    October 2016
  68. MINAKARI M, Badihian S, Jalalpour P, Sebghatollahi V, et al
    Etiology and outcome in patients with upper gastrointestinal bleeding: Study on 4747 patients in the central region of Iran.
    J Gastroenterol Hepatol. 2016 Oct 17. doi: 10.1111/jgh.13617.
    PubMed     Text format     Abstract available


    September 2016
  69. JUNG SW, Kim SY, Choe JW, Hyun JJ, et al
    Standard and double dose intravenous proton pump inhibitor injections for prevention of bleeding after endoscopic resection.
    J Gastroenterol Hepatol. 2016 Sep 16. doi: 10.1111/jgh.13597.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: